ANI Pharmaceuticals Sells Ontario Facility for $14.2M USD
Company Announcements

ANI Pharmaceuticals Sells Ontario Facility for $14.2M USD

ANI Pharmaceuticals Inc (ANIP) has released an update.

ANI Pharmaceuticals Canada Inc. has sold its former manufacturing facility in Oakville, Ontario to 1540700 Ontario Limited for $19.2 million CAD, which is around $14.2 million USD. The buyer has already paid a 5% deposit and will pay another 5% following a five-day due diligence period, with the rest due at closing. The deal, expected to finalize by the end of March 2024, includes standard closing conditions and indemnities, with the property sold “as is.” If the buyer defaults, ANI keeps the deposit; otherwise, it’s returned if the sale falls through due to ANI or the due diligence condition.

For further insights into ANIP stock, check out TipRanks’ Stock Analysis page.

Related Articles
GlobeNewswireANI Pharmaceuticals Announces the FDA Approval and Launch of L-Glutamine Oral Powder
TheFlyANI Pharmaceuticals announces FDA approval, launch of L-Glutamine oral powder
GlobeNewswireANI Pharmaceuticals Announces the FDA Approval and Launch of Naproxen Delayed-Release Tablets, USP
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!